UK markets close in 2 hours 9 minutes

ARCA biopharma, Inc. (ABIO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.3720+0.0120 (+0.36%)
At close: 04:00PM EDT
3.4100 +0.04 (+1.19%)
Pre-market: 08:39AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.3600
Open3.4100
Bid3.3400 x 100
Ask3.4300 x 400
Day's range3.3250 - 3.4600
52-week range1.5600 - 3.8800
Volume36,426
Avg. volume1,454,408
Market cap48.918M
Beta (5Y monthly)0.88
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Benzinga

    Small-Cap ARCA Biopharma Stock Soars On Merger Pact: The Details

    ARCA Biopharma Inc (NASDAQ:ABIO) and Oruka Therapeutics have entered into a definitive agreement to combine the companies in an all-stock transaction. Oruka Therapeutics is a privately held biotechnology company developing novel biologics for chronic skin diseases, including plaque psoriasis. The resulting entity will focus on advancing Oruka’s pipeline, including ORKA-001 (an IL-23p19 inhibitor) and ORKA-002 (an IL-17A/F inhibitor). Upon completion of the merger, the combined company plans to o

  • Simply Wall St.

    We're Not Very Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate

    Just because a business does not make any money, does not mean that the stock will go down. For example, although...